Financial Analysis: Standard BioTools Inc (LAB)’s Ratios Unveil Key Insights

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.74 million shares were traded. LAB stock price reached its highest trading level at $1.17 during the session, while it also had its lowest trading level at $1.1.

Ratios:

To gain a deeper understanding of LAB’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.09 and its Current Ratio is at 5.70. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.06.

On April 16, 2024, TD Cowen started tracking the stock assigning a Buy rating and target price of $3.50.

On April 04, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $3.25.Jefferies initiated its Buy rating on April 04, 2024, with a $3.25 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 28 ’25 when Casdin Partners Master Fund, L bought 4,820,959 shares for $1.06 per share. The transaction valued at 5,134,321 led to the insider holds 58,846,780 shares of the business.

Black Jeffrey G. bought 57,971 shares of LAB for $123,098 on Nov 12 ’24. On Sep 09 ’24, another insider, Taich Adam, who serves as the Former Officer of the company, bought 45,851 shares for $2.00 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LAB now has a Market Capitalization of 435833888 and an Enterprise Value of 171346800. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.50 while its Price-to-Book (P/B) ratio in mrq is 0.92. Its current Enterprise Value per Revenue stands at 0.982 whereas that against EBITDA is -1.453.

Stock Price History:

The Beta on a monthly basis for LAB is 1.74, which has changed by -0.57564574 over the last 52 weeks, in comparison to a change of 0.07019031 over the same period for the S&P500. Over the past 52 weeks, LAB has reached a high of $2.94, while it has fallen to a 52-week low of $0.97. The 50-Day Moving Average of the stock is -4.60%, while the 200-Day Moving Average is calculated to be -33.02%.

Shares Statistics:

It appears that LAB traded 1.96M shares on average per day over the past three months and 1481040 shares per day over the past ten days. A total of 377.53M shares are outstanding, with a floating share count of 364.90M. Insiders hold about 3.72% of the company’s shares, while institutions hold 73.82% stake in the company. Shares short for LAB as of 1743379200 were 17683207 with a Short Ratio of 9.00, compared to 1740700800 on 14165972. Therefore, it implies a Short% of Shares Outstanding of 17683207 and a Short% of Float of 9.41.

Dividends & Splits

Against a Trailing Annual Dividend Yield of 0.0

Most Popular